ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,722.26
      -0.19%
      US Tech 100
      19,474.00
      0.30%
      Dow Jones
      41,914.75
      -0.70%
      Brent Oil
      73.085
      -1.98%
      Bitcoin
      63,395.10
      -1.36%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Myriad Genetics Inc (MYGN)

      7. Myriad Genetics Inc (MYGN) News

      MYGN

      Myriad Genetics (MYGN)

      Myriad Genetics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MYGN
      DateTimeSourceHeadlineSymbolCompany
      09/23/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
      09/23/20244:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
      09/23/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
      09/18/20248:00AMGlobeNewswire Inc.Myriad Genetics to Share New Data Highlighting Genetic Testing Advancements at 2024 National Society of Genetic Counselors Annual ConferenceNASDAQ:MYGNMyriad Genetics Inc
      09/16/20242:30PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
      09/12/20244:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
      09/12/20244:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
      09/11/20243:26PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
      09/11/202410:05AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
      09/09/20245:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
      09/09/20242:52PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
      09/05/20248:00AMGlobeNewswire Inc.Myriad Genetics to Host Investor Event on October 9, 2024NASDAQ:MYGNMyriad Genetics Inc
      09/04/20247:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
      09/04/20247:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
      09/03/20244:33PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
      09/03/202410:11AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
      08/26/20244:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
      08/23/20244:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
      08/20/20244:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
      08/19/20242:46PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MYGNMyriad Genetics Inc
      08/14/20244:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MYGNMyriad Genetics Inc
      08/07/20248:22AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MYGNMyriad Genetics Inc
      08/06/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MYGNMyriad Genetics Inc
      08/06/20244:05PMGlobeNewswire Inc.Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%NASDAQ:MYGNMyriad Genetics Inc
      08/01/20244:05PMGlobeNewswire Inc.Myriad Genetics Advances International Reorganization and Completes Sale of EndoPredict Business to Eurobio ScientificNASDAQ:MYGNMyriad Genetics Inc
      07/31/20248:50AMGlobeNewswire Inc.Myriad Genetics Appoints Jennifer Fox as Chief Legal OfficerNASDAQ:MYGNMyriad Genetics Inc
      07/30/20248:00AMGlobeNewswire Inc.Myriad Genetics to Release Second Quarter 2024 Financial Results on August 6, 2024NASDAQ:MYGNMyriad Genetics Inc
      07/17/20248:00AMGlobeNewswire Inc.What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer RiskNASDAQ:MYGNMyriad Genetics Inc
      07/11/20249:00AMGlobeNewswire Inc.Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to TestingNASDAQ:MYGNMyriad Genetics Inc
      07/09/20249:00AMGlobeNewswire Inc.Myriad Genetics Announces Second Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority DateNASDAQ:MYGNMyriad Genetics Inc
       Showing the most relevant articles for your search:NASDAQ:MYGN